USA flag logo/image

An Official Website of the United States Government

SYNTHESIS OF ETIOCHOLANOLONE FOR USE IN APLASTIC ANEMIA

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
2958
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
2958
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Progenics, Inc.
442 West 44nd Street New York, NY 10036
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1986
Title: SYNTHESIS OF ETIOCHOLANOLONE FOR USE IN APLASTIC ANEMIA
Agency: HHS
Contract: N/A
Award Amount: $495,000.00
 

Abstract:

THE USE OF -ETIOCHOLANOLONE AND -ETIOCHOLANOLONE IN APLASTIC ANEMIA SHOWS PROMISE, BUT THE SUPPLY IS VERY LIMITED DUE TO THE LACK OF A GOOD SYNTHESIS FROM READILY AVAILABLE MATERIAL. -ETIOCHOLANOLONE WOULD BE LESS TRAUMATIC TO THE PATIENT, BUT IS NOT READILY AVAILABLE AGAIN FOR THE ABOVE MENTIONED REASON. DURING PHASE I, REASONABLE AND ECONOMIC SYNTHESES OF -ETIOCHOLANOLONE AND -ETIOCHOLANOLONE FROM READILY AVAILABLE RAW MATERIALS HAVE BEEN SUCCESSFULLY DEVELOPED THUS PERMITTING THE SYNTHESIS OF SUFFICIENT QUANTITIES OF THESE AGENTS FOR LARGE-SCALE CLINICAL TRIALS. PHASE II FUNDS ARE BEING SOUGHT TO CARRY OUT CLINICAL TRIALS IN APLASTIC ANEMIA AS WELL AS TOXICOLOGY STUDIES WITH COMPETENT INVESTIGATORS.

Principal Investigator:

Norman Applezweig
Principal Investigator
2122650650

Business Contact:

Small Business Information at Submission:

Progenics, Inc.
442 West 44nd Street New York, NY 10036

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No